Keros Therapeutics, Inc. (KROS)

NASDAQ: KROS · Real-Time Price · USD

9.97

-0.10 (-0.99%)

At close: Jul 29, 2026, 4:00 PM EDT

9.95

-0.02 (-0.25%)

After-hours: Jul 29, 2026, 4:27 PM EDT

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
Developing Novel Therapeutics	244.06M	3.55M	151.00K		20.10M		10.00M
Total	244.06M	3.55M	151.00K		20.10M		10.00M